Recommendations for using smallpox vaccine in a pre-event vaccination program. Supplemental recommendations of the Advisory Committee on Immunization Practices (ACIP) and the Healthcare Infection Control Practices Advisory Committee (HICPAC).
about
Smallpox vaccine: the good, the bad, and the ugly.Risks of serious complications and death from smallpox vaccination: a systematic review of the United States experience, 1963-1968The effects of post-exposure smallpox vaccination on clinical disease presentation: addressing the data gaps between historical epidemiology and modern surrogate model dataRisks Associated With Smallpox Vaccination in Pregnancy: A Systematic Review and Meta-analysis.Finding and removing highly connected individuals using suboptimal vaccines.Preparedness for a smallpox outbreak: comparing metrics for assessing levels of vaccination among health-care workers by state.Prophylaxis and treatment of pregnant women for emerging infections and bioterrorism emergencies.Deaths following vaccination: What does the evidence show?Preferential amplification of CD8 effector-T cells after transcutaneous application of an inactivated influenza vaccine: a randomized phase I trial.Can vaccinia virus be replaced by MVA virus for testing virucidal activity of chemical disinfectants?The social, political, ethical, and economic aspects of biodefense vaccines.Biological activity of an intravenous preparation of human vaccinia immune globulin in mouse models of vaccinia virus infection.In vitro efficacy of brincidofovir against variola virus.Efficacy of cidofovir in a murine model of disseminated progressive vaccinia.Postexposure prevention of progressive vaccinia in SCID mice treated with vaccinia immune globulinVaccinia virus induces rapid necrosis in keratinocytes by a STAT3-dependent mechanismReasons physicians accepted or declined smallpox vaccine, February through April, 2003.Hospital recruitment for the Smallpox Pre-Event Vaccination Program: experiences from Florida, Nebraska, New Jersey, and Tennessee, December 2002-June 2003Validity of self-assessment of skin reaction after smallpox vaccination.The public acceptance of smallpox vaccination to fight bioterrorism in Japan: results of a large-scale opinion survey in Japan.Passive immunotherapies protect WRvFire and IHD-J-Luc vaccinia virus-infected mice from lethality by reducing viral loads in the upper respiratory tract and internal organsRole of cell signaling in poxvirus-mediated foreign gene expression in mammalian cellsVaccinia viruses: vaccines against smallpox and vectors against infectious diseases and tumors.Public health emergency planning for children in chemical, biological, radiological, and nuclear (CBRN) disastersSecondary and tertiary transmission of vaccinia virus from US military service member.Vaccinia virus infection during murine pregnancy: a new pathogenesis model for vaccinia fetalis.Safety, immunogenicity, and surrogate markers of clinical efficacy for modified vaccinia Ankara as a smallpox vaccine in HIV-infected subjects.Safety and immunogenicity of modified vaccinia Ankara in hematopoietic stem cell transplant recipients: a randomized, controlled trial.Antimicrobial peptides, skin infections, and atopic dermatitisSafety, reactogenicity and immunogenicity of Francisella tularensis live vaccine strain in humans.Ischemic cardiac events and other adverse events following ACAM2000(®) smallpox vaccine in the Vaccine Adverse Event Reporting System.Injection Site Lichenoid Dermatitis Following Pneumococcal Vaccination: Report and Review of Cutaneous Conditions Occurring at Vaccination Sites.ORFeome approach to the clonal, HLA allele-specific CD4 T-cell response to a complex pathogen in humans.Generalized vaccinia 2 days after smallpox revaccination.Can we capitalize on the virtues of vaccines? Insights from the polio eradication initiativeLocal Preparedness for Infectious Disease Outbreaks: A Qualitative Exploration of Willingness and Ability to Respond
P2860
Q24520563-9EA49025-EF1B-40F8-9BC7-9F8AAF08AB37Q24799168-EB7934E7-B28C-49A9-B4FE-CAC634E49C0FQ26996686-3758BA94-8F2B-46B0-81B6-0171D318EAC1Q30203654-10EF2A46-DBE6-45D7-B455-E3ABDA94ECC9Q30224717-44F8471F-DE46-41CB-B840-55511317BEA3Q30230391-EBA6BE29-1991-45D8-BB92-FAD50F658449Q30359710-23E8BE01-2EEE-4718-8419-C462ADA3FEC8Q33165769-E52DCEC3-E71B-4D78-8B15-265C9A40687DQ33593103-60917BA0-1CE8-4A74-8A3B-6D70B8962B77Q33614263-CC44FE8E-20B1-4BD1-8EF1-E2903816775AQ33701545-7895D5A1-6586-4AEA-A753-3A55841E3916Q33883711-1C86E7BB-9035-4D5C-A81F-F9164D2C012CQ34057540-FF54BC4C-CE2E-447F-A4BB-4E53A10D2249Q34140816-1D24B3AD-FE79-4478-AF19-FEC11F1D6EDBQ34484027-7AF3CB64-A0CE-474D-A2F8-BB51D034E1ACQ34566254-B25B53D0-8802-4FE4-8D6B-255377EC56D3Q34740233-D0873138-EFD7-4D4F-84F5-8995BF726CC2Q34756892-AC6CA651-BCB8-4902-AF34-6FBFA2E7A3CAQ34757936-7C084C31-7AC5-44FB-AF8A-E1A7B1F1EA16Q35166832-982C46F4-2898-4AE6-880C-31DA4B159E78Q35192889-E5664F67-3AB4-4825-BD3F-CBE5BEFBE0E6Q35292450-74F88140-63CF-49E6-8471-A32B4551C5AEQ35571248-2E42C3E6-7CD5-4D9D-B478-B0BDFF46B4DAQ35681611-ED252346-F382-4C57-BEFF-5918AE4321E7Q36039584-4464AD99-3F6B-44A7-8764-32B3AC573DC9Q36509448-0FEBD89C-A273-4D1D-BEF8-F494769B42A6Q36727280-9336D17F-B50F-4183-B298-89A8655FB0BDQ36846282-C734ACC9-A39E-42B0-B211-E64DCDB40229Q37213664-35FC32F3-D10A-4AA8-8D20-E056EC4BE8BBQ37305453-D8762A02-74B0-42F2-B0B8-2D0B9D5BBCB4Q38222113-434F00A0-0AC3-401E-9759-77C319EE8937Q38779212-8696358A-7D22-4AF0-8646-8BA37D791680Q41848044-8D3E2904-51CD-4F3A-96E6-92C104DCB7FDQ42590565-4C2F99CE-D241-4273-AB2B-D793AA0F693CQ56969882-1967AAF7-5600-4410-B634-2F0336869942Q58558334-F506B6C2-11B2-41E0-94AC-B8C1CFFE8BD1
P2860
Recommendations for using smallpox vaccine in a pre-event vaccination program. Supplemental recommendations of the Advisory Committee on Immunization Practices (ACIP) and the Healthcare Infection Control Practices Advisory Committee (HICPAC).
description
2003 nî lūn-bûn
@nan
2003 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2003 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2003年の論文
@ja
2003年論文
@yue
2003年論文
@zh-hant
2003年論文
@zh-hk
2003年論文
@zh-mo
2003年論文
@zh-tw
2003年论文
@wuu
name
Recommendations for using smal ...... s Advisory Committee (HICPAC).
@ast
Recommendations for using smal ...... s Advisory Committee (HICPAC).
@en
type
label
Recommendations for using smal ...... s Advisory Committee (HICPAC).
@ast
Recommendations for using smal ...... s Advisory Committee (HICPAC).
@en
prefLabel
Recommendations for using smal ...... s Advisory Committee (HICPAC).
@ast
Recommendations for using smal ...... s Advisory Committee (HICPAC).
@en
P2093
P1476
Recommendations for using smal ...... s Advisory Committee (HICPAC).
@en
P2093
Advisory Committee on Immunization Practices
Benjamin Schwartz
Christine G Casey
Healthcare Infection Control Practices Advisory Committee
Larry J Anderson
Lisa D Rotz
Michele L Pearson
Rafael Harpaz
Raymond A Strikas
P577
2003-04-01T00:00:00Z